{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T20:16:26Z","timestamp":1773260186853,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"20","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MRMC"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>The cardiovascular complications of type 2 diabetes mellitus (T2DM) including myocardial\ninfarction, heart failure, peripheral vascular disease and, stroke and retinopathy, nephropathy and neuropathy\nare microvascular complications. While the newer therapies like glitazones or even dipeptidylpeptidase-\nIV (DPP-IV) inhibitors increase the risk of therapy, the Glucagon Like Peptide-1 Receptor\nAgonists (GLP-1RAs), were reported as suitable alternates. The GLP-1RAs reduce major adverse cardiovascular\nevents (MACE), have anti-atherogenic potential, and possess pleiotropic activity. The\nGLP-1RAs were found to improve neuroprotection, enhance neuronal growth, reduce the incidence of\nstroke, and improve central insulin resistance. The GLP-1RAs are beneficial in improving the glycemic\nprofile, preventing macroalbuminuria and reducing the decline in eGFR and enhancing renal protection.\nThe renal benefits of add-on therapy of GLP-1RAs with SGLT-2 inhibitors have composite renal\noutcomes such as suppression of inflammatory pathways, improvement in natriuresis, diuresis, found\nto be nephroprotective. Improvement in glycemic control with a reduction in body weight and intraglomerular\npressure and prevention of tubular injury makes the GLP-1RAs as suitable add-on therapies\nin improving cardiorenal outcomes. Obesity, an important contributor to insulin resistance and a reduction\nin weight, is an essential therapeutic option in addressing diabetic-obesity. It also reduces the\ndamage to blood-retinal-barrier, thus beneficial in halting the development of diabetic retinopathy. In\ndiabetic complications, glycemic control, addressing insulin resistance through weight loss, controlling\natherosclerosis through anti-inflammatory effects and cardio-renal-neuro protection, makes GLP-1RAs\na suitable therapeutic strategy on long-term treatment of T2DM. This review discusses the role of\nGLP-1RAs in diabetes, the dosage, mono or combination therapy with other antidiabetics in long-term\ntreatment and its effect in uncontrolled diabetes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389557521666210422114909","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T06:34:40Z","timestamp":1619159680000},"page":"3166-3182","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Role of GLP-1 Analogs in the Management of Diabetes and its Secondary\nComplication"],"prefix":"10.2174","volume":"21","author":[{"given":"Ponnurengam Malliappan","family":"Sivakumar","sequence":"first","affiliation":[{"name":"Center for Molecular Biology, Institute of Research and Development, Duy Tan University, Da Nang, Vietnam"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Premkumar","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, K. K College of Pharmacy, Gerugambakkam, Chennai, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veluchamy","family":"Prabhawathi","sequence":"additional","affiliation":[{"name":"Multidisciplinary Research Unit, Coimbatore Medical College Hospital, Coimbatore - 641014, Tamil Nadu, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav Kumar","family":"Prabhakar","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratory Sciences, Lovely Professional University, Punjab, India-144411"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Mini-Reviews in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/192978","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.eurekaselect.com\/192978\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/eurekaselect.com\/article\/download\/192978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T19:27:20Z","timestamp":1641324440000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/192978\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":0,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389557521666210422114909","relation":{},"ISSN":["1389-5575"],"issn-type":[{"value":"1389-5575","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-11-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-22","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}